Tectonic Therapeutic
AVRO · NASDAQ
AVRO key statistics
- Market cap
- —
- Price-earnings ratio
- 2.07
- Dividend yield
- —
- Average volume
- 503.71K
- Volume
- 100.19K
- Open price
- $21.22
- High today
- $22.44
- Low today
- $20.99
- 52 Week high
- $1.92
- 52 Week low
- $0.5719
Tectonic Therapeutic (AVRO) at a glance
As of Oct 20, 2026, Tectonic Therapeutic (AVRO) shares are priced at $21.83, giving the company a price-to-earnings ratio of 2.07.
Today the stock has traded between $20.99 and $22.44. The current price is 4.0% above the day's low and 2.7% below its high.
Volume so far is 100.19K shares, below the average of 503.71K shares a day.
Over the past year Tectonic Therapeutic has ranged from $0.5719 to $1.92, and now sits 1577% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.